These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24570393)

  • 1. Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma.
    Isfoss BL; Busch C; Hermelin H; Vermedal AT; Kile M; Braathen GJ; Majak B; Berner A
    Virchows Arch; 2014 Apr; 464(4):473-88. PubMed ID: 24570393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
    Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for γ-H2AX.
    Yamada T; Toyoda T; Matsushita K; Cho YM; Akagi JI; Morikawa T; Mizuta Y; Ogawa K
    Arch Toxicol; 2021 Feb; 95(2):715-726. PubMed ID: 33211169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
    DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
    Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal and neoplastic urothelial stem cells: getting to the root of the problem.
    Ho PL; Kurtova A; Chan KS
    Nat Rev Urol; 2012 Oct; 9(10):583-94. PubMed ID: 22890301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
    Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
    Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer stem cells.
    Tran MN; Goodwin Jinesh G; McConkey DJ; Kamat AM
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):387-95. PubMed ID: 20955163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.
    Shin K; Lim A; Odegaard JI; Honeycutt JD; Kawano S; Hsieh MH; Beachy PA
    Nat Cell Biol; 2014 May; 16(5):469-78. PubMed ID: 24747439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study.
    Isfoss BL; Holmqvist B; Sand E; Forsell J; Jernström H; Olsson H
    BMC Cancer; 2018 Feb; 18(1):230. PubMed ID: 29486751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
    Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
    Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
    Rodriguez Pena MDC; Chaux A; Eich ML; Tregnago AC; Taheri D; Borhan W; Sharma R; Rezaei MK; Netto GJ
    Virchows Arch; 2019 Sep; 475(3):349-356. PubMed ID: 31300876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of denuded urothelium in bladder biopsy.
    Levi AW; Potter SR; Schoenberg MP; Epstein JI
    J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?
    Herr HW; Al-Ahmadie H; Dalbagni G; Reuter VE
    BJU Int; 2010 Nov; 106(10):1499-501. PubMed ID: 20346034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
    Yang YM; Chang JW
    Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
    Siddiqui Z; Srivastava AN; Sankhwar SN; Dalela D; Singh V; Zaidi N; Fatima N; Bano I; Anjum S
    Br J Biomed Sci; 2020 Apr; 77(2):69-75. PubMed ID: 31718471
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
    Wu CT; Lin WY; Chen WC; Chen MF
    Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
    Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
    Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
    Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
    Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.